Definium Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +21.5% | +0.0% | – | – | – | – | -83.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +86.7% | +4.0% | +35.4% | +33.4% | +80.2% | |
| – | – | – | – | – | – | +310.2% | -48.9% | +38.4% | -7.5% | +26.0% | |
| – | +17.7% | +1,005.3% | -30.4% | -46.0% | +7,057.1% | +184.1% | -29.3% | +36.7% | +14.0% | +60.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +118.9% | +316.4% | -38.5% | +148.2% | +140.1% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.